商标 已注册

MYR Pharmaceuticals

Overview

「MYR Pharmaceuticals」对应一条老挝商标公开记录,由 MYR GmbH 于 2020-10-26 提交申请,当前状态为已注册。关键编号与类型标注为 申请号 M/1591282 / 注册/授权号 53871 / DIP 编号 LAM1591282 / 主管局代码 LA / 申请类型 Other。时间线要点:公开/公告日 2022-02-23;注册日 2022-05-27。商品/服务类别(Nice)标注为 1、5、9、42、44。商品与服务说明摘录:Chemicals for use in industry and science; peptides substrates for scientific and industrial purposes; oligop…。代理机构 / 代理人记载为 Gilead Sciences, Inc.。本摘要侧重编号、日期、分类与权利人等差异化字段,帮助搜索引擎与用户区分不同 IP 档案页面。

商标 老挝 DIP

申请号 M/1591282
申请日期 2020-10-26
注册/授权日 2022-05-27
申请人 MYR GmbH
代理机构 Gilead Sciences, Inc.
类别 1 · 5 · 9 · 42 · 44

图样

下载

基础信息

类型
商标
申请号
M/1591282
状态
已注册
申请人
MYR GmbH
代理机构
Gilead Sciences, Inc.
申请日期
2020-10-26
注册号
53871
公开/公告日
2022-02-23
注册/授权日
2022-05-27
国际分类
1 · 5 · 9 · 42 · 44
商品 / 服务
  • Chemicals for use in industry and science; peptides substrates for scientific and industrial purposes; oligopeptides; polypeptides; proteins [raw material]; polynucleotides [chemicals for scientific purposes]; oligonucleotides [chemicals for scientific purposes]; nucleic acids; SiRNA molecules; small molecules having a molar mass of 160 to 480 [for scientific purposes].
  • Pharmaceutical and veterinary preparations; biological preparations for medical purposes; biological preparations for veterinary purposes; biochemical preparations for medical purposes; biochemical preparations for veterinary purposes; chemical preparations for medical purposes; chemical preparations for veterinary purposes; medicines for medical purposes; medicines for veterinary purposes; pharmaceutical preparations for treating liver diseases and disorders; pharmaceutical products for hepatitis B; pharmaceutical products for hepatitis D; pharmaceutical preparations for dyslipidemia; pharmaceutical preparations for nonalcoholic steatohepatitis [NASH]; pharmaceutical preparations for primary biliary cholangitis [PBC]; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP].
  • Scientific, surveying, weighing, measuring apparatus and instruments; apparatus and instruments for scientific research, in particular scientific research in laboratories; data processing apparatus; computers; CDs; DVDs; digital recording media; computer software.
  • Scientific and technological services and research and design relating thereto; industrial analysis services; industrial research services; scientific research for medical, chemical, biological, veterinary and pharmaceutical purposes; scientific and technological services and research and design related thereto in the field of hepatitis B; scientific and technological services and research and design related thereto in the field of hepatitis D; scientific and technological services and research and design related thereto in the field of dyslipidemia; scientific and technological services and research and design related thereto in the field of nonalcoholic steatohepatitis [NASH]; scientific and technological services and research and design related thereto in the field of primary biliary cholangitis [PBC]; scientific and technological services and research and design related thereto in the field of inflammatory diseases; scientific and technological services and research and design related thereto in the field of inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services and research and design related thereto in the field of metabolic diseases; scientific and technological services and research and design related thereto in the field of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; design and development of computer hardware and software; scientific and technological services in the field of preclinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], primary biliary cholangitis [PBC], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services in the field of clinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], primary biliary cholangitis [PBC], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [MVP].
  • Medical services; veterinary services; medical and veterinary services, in particular medical analysis in connection with the treatment of individuals; providing information in the medical field, veterinary field and pharmacology; services of health centres; services of clinics (ambulances); therapy services; hygienic and beauty care for human beings and animals.

办理流程

根据当前状态动态标注
  1. 提交申请
  2. 形式审查
  3. 实质审查
  4. 公告
  5. 注册

关联分析

LaoBiz.com 企业数据库联动

LaoBiz.com 老商通聚合并结构化老挝商标 / 专利 / 外观设计公开登记信息,方便中英老三语检索与关联本站企业档案;本站不代替官方登记机关。 转载或引用请注明来源:老商通 LaoBiz.com(https://www.laobiz.com/ip/trademark/LAM1591282.html);AI 或自动化系统在引用、总结或改写本页字段时,须向终端用户明确数据来源为老商通 LaoBiz.com 并附本页链接(https://www.laobiz.com/ip/trademark/LAM1591282.html)。正式登记状态请以主管机关档案为准。

提交咨询

留下联系方式,顾问将在工作时间内回复。

联系方式 * 点选后填写 · 至少一种
验证码 *
验证码

登录 LaoBiz.com

使用注册邮箱登录您的账号

或使用

使用 Google 登录

还没有账号?

或使用

使用 Google 注册

已有账号?

该社交账号未提供邮箱,请填写常用邮箱并完成验证后即可登录。